No Detail Found!

Enhancing Bioavailability with Oromucosal Products: Opportunities and Challenges

Author(s)
Syed Muhammad Talha Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan
Pakeeza Zainab Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan
Mamoona Khalid Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan
Areej Javed Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan
Abstract
The oral mucosa offers an attractive route for the systemic delivery of drugs. The bioavailability and effectiveness of many drugs can be increased by administering them through the oral mucosa which bypasses the first-pass metabolism effect. This article will discuss principles, application areas, benefits & drawbacks as well as possible future perspectives for the study and development of oromucosal drug delivery systems. Among the critical benefits of administering drugs via the mouth is that it starts acting fast, is easily absorbed into the bloodstream, makes it easier for patients to follow their prescriptions as well and offers more freedom in terms of dosage control. The article emphasizes innovative technologies such as nanoparticulate formulations as well as microfabricated devices which are slated to improve drug targeting and delivery. It also touches on such related issues as taste masking, variability in bioavailability, and regulatory concerns.
Publication Details
Page(s) 37-48
Published Journal: Global Pharmaceutical Sciences Review, Volume: 8, Issue: 4, Year: 2023

Request the full text from PASTIC

Keywords
Patient Compliance, Bioavailability, Drug Targeting, Oromucosal Drug Delivery, Safety Considerations, Future Directions, Innovative Technologies
References
Bastos F.,Pinto A. R.,Nuñes A. J. A.,Simões S. .2022 .Oromucosal products - Market landscape and innovative technologies: A review. Journal of Controlled Release, 348 : 305-320.
.2022 .. , 05 : .
Lingamchetty TN,Hosseini SA,Saadabadi A. Midazolam. .2023 .Treasure Island (FL): StatPearls Publishing; 2024 Jan-. , : .
.2022 .. , 05 : .
Zhang H.,Streisand J.,J. B. J. .2002 .Oral mucosal drug delivery. Clinical Pharmacokinetics, 41(9) : 00003088-680.
. .Phenol (Oromucosal route) proper use - Mayo Clinic. , : 1.
Masloh S,Culot M,Gosselet F,Chevrel A,Scapozza L,Zeisser Labouebe M. Challenges L . .Opportunities in the Oral Delivery of Recombinant Biologics. , 515(5) : 1415.
. .. , : .
Rossi S.,Sandri G.,Caramella C. .2005 .Buccal drug delivery: A challenge already won? Drug Discovery Today. , 05(1) : 59-65.
Madhav N. V. S.,Shakya A. K.,Shakya P.,Singh K. .2009 .Orotransmucosal drug delivery systems: A review. Journal of Controlled Release, 07(1) : 2-11.
Tian Y.,Orlu M.,Woerdenbag H. J.,Scarpa M.,Kiefer O.,Kottke D.,Visser J. C. .2019 .Oromucosal films: from patient centricity to production by printing techniques. Expert Opinion on Drug Delivery, 1652(9) : 981-993.
Lou J,Duan H,Qin Q,Teng Z,Gan F,Zhou X,Zhou X. . .Advances in Oral Drug Delivery Systems: Challenges and Opportunities. , 15(2) : .
Jacob S.,Boddu S. H. S.,Bhandare R. R.,Ahmad S.,Nair A. B. .2023 .Orodispersible Films: current innovations and emerging trends. Pharmaceutics, 2753(12) : .
.2023 .amore-efficient-technology-for-oromucosaldrug-delivery/. , : .
Tian Y.,Orlu M.,Woerdenbag H. J.,Scarpa M.,Kiefer O.,Kottke D.,Sjöholm E.,Öblom H.,Sandler N.,Hinrichs W. L. J.,Frijlink H. W.,Breitkreutz J.,Visser J. .2019 .Oromucosal films: from patient centricity to production by printing techniques. Expert Opinion on Drug Delivery, 1652(9) : 981-993.
MA Überall . .A Review of Scientific Evidence for THC: CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain. J Pain Res, 13 : 399-410.
. .. , : .
Krampe R.,Visser J.C.,Frijlink H.W.,Breitkreutz J.,Woerdenbag H.J.,Preis M. .2016 .Oromucosal film preparations: points to consider for patient centricity and manufacturing processes. Expert Opinion on Drug Delivery, 13 : 493-506.
Cilurzo F.,Musazzi U.M.,Franzè S.,Selmin F.,Minghetti P. .2017 .Orodispersible dosage forms: biopharmaceutical improvements and regulatory requirements. Drug Discovery Today, 23 2 : 251-259.
Ferreira AS,Macedo C,Silva AM,Delerue-Matos C,Costa P,Rodrigues F . .Natural Products for the Prevention and Treatment of Oral Mucositis-A Review. Int J Mol Sci, 23(8) : 4385.
Xu D.,Lan C.,Kou J.,Yao S.,Becker B.,Kendrick K. M. .2024 .Oromucosal administration of oxytocin: the development of 'Oxipops. , 16(3) : .
Madhav N. V. S.,Shakya A. K.,Shakya P.,Singh K. .2009 .Orotransmucosal drug delivery systems: A review. Journal of Controlled Release, 07(1) : 2-11.
Moini J.,LoGalbo A.,Schnellmann J. G. .2023 .Drug approval and drug regulations. -323-95974- 2, : 00031-1.
0

Citations

0

Downloads

83

Views